Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. CK Life Sciences Int'l., (Holdings) Inc.
  6. News
  7. Summary
    775   KYG2176J1058

CK LIFE SCIENCES INT'L., (HOLDINGS) INC.

(775)
  Report
Delayed Hong Kong Stock Exchange  -  09:20 2022-10-06 pm EDT
0.6300 HKD   -1.56%
09/01CK Life Sciences Int'l., Inc. Announces Retirement of Independent Non-Executive Director and Change in Composition of the Remuneration Committee
CI
08/02CK Life Sciences' H1 Profit Down 35%
MT
08/02CK Life Sciences Int'l., Inc. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
SummaryQuotesChartsNewsCalendarCompanyFinancialsFunds 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

CK Life Sciences Investors Acquire Stake in Pharus for $5.5 Million Each

07/26/2022 | 03:55am EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
CK HUTCHISON HOLDINGS LIMITED -0.77% 44.9 Delayed Quote.-9.44%
CK LIFE SCIENCES INT'L., (HOLDINGS) INC. -1.56% 0.63 Delayed Quote.-13.51%
All news about CK LIFE SCIENCES INT'L., (HOLDINGS) INC.
09/01CK Life Sciences Int'l., Inc. Announces Retirement of Independent Non-Executive Directo..
CI
08/02CK Life Sciences' H1 Profit Down 35%
MT
08/02CK Life Sciences Int'l., Inc. Reports Earnings Results for the Half Year Ended June 30,..
CI
07/26CK Life Sciences Investors Acquire Stake in Pharus for $5.5 Million Each
MT
05/20CK LIFE SCIENCES INT'L., (HOLDINGS) INC. : Ex-divid..
FA
03/15CK Life Sciences Int'l., Inc. Announces Ordinary Final Cash Dividend for the Year Ended..
CI
03/15CK Life Sciences Int'l., Inc. Reports Earnings Results for the Full Year Ended December..
CI
2021CK Hutchison : CK Asset profits rise in H1
RE
2021CK Life Sciences 'l : Posts Higher Profit, Revenue in H1
MT
2021Ck Life Sciences Int'l., Holdings Inc. Reports Earnings Results for the Half Year Ended..
CI
More news
Financials
Sales 2021 5 402 M 688 M 688 M
Net income 2021 163 M 20,7 M 20,7 M
Net Debt 2021 5 311 M 677 M 677 M
P/E ratio 2021 43,8x
Yield 2021 1,35%
Capitalization 6 151 M 784 M 784 M
EV / Sales 2020 2,77x
EV / Sales 2021 2,30x
Nbr of Employees 1 829
Free-Float 25,0%
Chart CK LIFE SCIENCES INT'L., (HOLDINGS) INC.
Duration : Period :
CK Life Sciences Int'l., (Holdings) Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CK LIFE SCIENCES INT'L., (HOLDINGS) INC.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Managers and Directors
Ying Choi Yu Chief Operating Officer & Vice President
Hing Lam Kam President & Executive Director
Yiu Leung Mo Chief Financial Officer
Tzar Kuoi Li Chairman
Kean Meng Toh Executive Director & Chief Scientific Officer
Sector and Competitors